This party could hardly go on forever. Does seem to be seriously re-rated since a week ago, though. Bring on:- first dosage- Calimmune results - Gradalis updatesYour $2.12 is likely to be well and truly paid back soon, mate. :)
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint